Stay updated on Safety of Tarlatamab in Adults With SCLC Clinical Trial
Sign up to get notified when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.

Latest updates to the Safety of Tarlatamab in Adults With SCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe footer revision updated from v3.6.2 to v3.6.3. This represents a minor site/template update and does not alter page content.SummaryDifference0.0%

- Check19 days agoChange DetectedA new release entry, Revision: v3.6.2, has been added to the study record history and the older Revision: v3.6.0 entry has been removed. This updates the documented software version reflected on the page.SummaryDifference0.0%

- Check34 days agoChange DetectedRecruitment status updated to no longer look for participants, indicating enrollment has closed. The history also shows a new revision (v3.6.0) to the record, following the previous v3.5.5.SummaryDifference0.2%

- Check41 days agoChange DetectedA new revision entry, v3.5.5, was added to the history, replacing the prior v3.5.4.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page footer revision label changed from v3.5.3 to v3.5.4, indicating a minor version update to the page.SummaryDifference0.0%

- Check77 days agoChange DetectedThe history now includes a new revision entry labeled v3.5.3 and removes the previous v3.5.2, indicating the record has been updated to a newer version.SummaryDifference0.0%

Stay in the know with updates to Safety of Tarlatamab in Adults With SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.